Private Equity-Backed Lantheus Faces a Make-Or-Break Year

NEW YORK ( TheDeal) -- Although it has solved its supply chain issues and installed a growth strategy, private equity-backed Lantheus Medical Imaging faces a make-or-break year when it comes to stopping a decline in sales and getting itself back in the good graces of the rating agencies.

"I think 2014 will be a critical year," said Moody's Investors Service analyst Michael Levesque, who has a Caa3 negative rating on the medical device company. "Either [Lantheus] turns around after the resolution of the supply chain issues or they continue to struggle and liquidity weakens."

Read more from:

More from Mergers and Acquisitions

Sprint, T-Mobile Might Have to Do More Than Make Promises to Get Deal Approved

Sprint, T-Mobile Might Have to Do More Than Make Promises to Get Deal Approved

Xerox Received Interest From HPQ Before Fuji Deal: Sources

Xerox Received Interest From HPQ Before Fuji Deal: Sources

Divestitures at Newell Expected in Weeks: Wells Fargo

Divestitures at Newell Expected in Weeks: Wells Fargo

In Biopharma M&A, 'Where There's Real Innovation There's Someone Willing to Pay'

In Biopharma M&A, 'Where There's Real Innovation There's Someone Willing to Pay'

AT&T Expert Calls DOJ's Model 'Theoretically Unsound'

AT&T Expert Calls DOJ's Model 'Theoretically Unsound'